PHOTO
Dubai: (MoHAP) has signed a Memorandum of Understanding (MoU) with Sobi Middle East and Bayti Home Healthcare. The initiative covers all patients with hemophilia "A" and "B" in all the Emirates of the Country, who have difficulties in visiting the medical centers, in order to improve their adherence to the treatment protocols prescribed by their doctors.
The MoU was signed at MoHAP headquarters by HE Dr. Amin Hussein Al Amiri, Assistant Undersecretary of the Ministry of Health and Prevention’s Public Health Policy and Licenses, Ahmed Abu El Dahab, Director-General, Sobi Middle East and Rajiv Nakani, Executive Director, Bayti Home Healthcare.
Cooperation and Coordination
Dr. Ruqaya Al Bastaki, Director of MoHAP’s Drug Department, said: “The one-year renewable MoU is part of MoHAP’s ongoing humanitarian initiatives to bolster low-income patients. Such initiatives would help achieve the community responsibility in cooperation with the government and private authorities and also enable patients to find out early healing solutions, considering the confidentiality of patients’ information registered in the program.”
Al Bastaki went on saying: “The importance of this initiative lies in providing a competent, highly-qualified and well-trained nursing staff on home healthcare and licensed by MoHAP or local health authorities as well. Through this initiative, we aim to provide more services for patients with hemophilia at home, in accordance with a treatment plan for each patient. This plan includes educating patients on this disease, explaining in detail the drug mechanism and how to use it and acquainting patients with how to take and store medicines properly.”
Sponsored by Sobi Middle East and implemented by Bayti Home Healthcare under the supervision of MoHAP, the initiative highlights the importance of the strict adherence and commitment to the treatment plan, as well as the
importance of providing patients with the necessary psychological support and the regular communication with the doctor to follow-up the patient medical conditions through the assigned nurse.
The representatives of Sobi Middle East and Bayti Home Healthcare stressed the importance of MoHAP’s supervision of the initiative, in order to promote community responsibility, alleviate patients suffering and enabling them to follow up their treatment, as per the treatment plan for each patient by his doctor.
Hemophilia is a chronic hemorrhagic disorder in which blood can’t clot normally and causes prolonged periods of bleeding more than normal due to the lack of proper clotting factor in the blood. Hemophilia A is the most common type of the disease.
-Ends-
For further information, please contact:
Heba Alshahed
Misbar Communications
00971505784522 heba.alshahed@misbar-me.com
Osama Al Ansari
Misbar Communications
00971509194522 Osama@misbar-me.com
Mahmoud Soliman
Misbar Communications
00971505874522 mahmoud.soliman@misbar-me.com
Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.
